JANUARY 15 – 16: Advisory Board to the European AIDS Treatment Group (EATG), Brussels.
JANUARY 17: SWAPS event, Paris.
JANUARY 25: Meeting with the Russian delegation to the WHO Executive Board, Geneva.
JANUARY 30: “HIV/AIDS in Eastern Europe and Central Asia”, The Netherlands Ambassadors Conference, The Hague. SPEAKER
JANUARY 31 – FEBRUARY 1: HepHIV 2017 Conference “HIV and Viral Hepatitis: Challenges of Timely Testing and Care”, Malta. SPEAKER
FEBRUARY 9: “Addressing Challenges in Global Health Security”, Geneva Centre for Security Policy, Geneva. SPEAKER
FEBRUARY 14 – 15: Aeras Board of Directors, Washington DC.
FEBRUARY 17: “Ethics and Principles for Science and Society Policymaking: The Brussels Declaration”, American Association for the Advancement of Science (AAAS) Annual Meeting, Boston. SPEAKER
FEBRUARY 20: Global Health Centre – Senior Fellows’ Meeting, Geneva.
FEBRUARY 23: “Conversation with Ruth Dreifuss on the High-Level Panel on Access to Medicines”, Global Health Centre at the Graduate Institute, Geneva. MODERATOR
FEBRUARY 28: Signature of the Paris Declaration on The Fast-Track Cities Initiative by Odessa city, Odessa. SPEAKER
MARCH 4: Interdisciplinary Program in Translational Medicine, Brussels. SPEAKER
MARCH 14: “Decriminalizing Drug Use and Possession to Advance Health and Human Rights”, Sixtieth session of the Commission on Narcotic Drugs, Vienna. MODERATOR
MARCH 14: Meeting with Amb. Marcel Pesko, Director of Conflict Prevention Center, OSCE, Vienna.
MARCH 20 – 21: Global Drug Policy Program, Open Society Foundations, Advisory Board, New York.
MARCH 23: Meeting on the Evaluation of the 5% Initiative, Paris. CHAIR
MARCH 28: “Culture Cures and Kills Symposium II”, AFEW, Amsterdam. SPEAKER
APRIL 3: Team retreat, Vilnius.
APRIL 4 – 5: Harm reduction Eastern European regional conference, Vilnius. SPEAKER
APRIL 6: Biovision, Lyon. SPEAKER
APRIL 24 – 28: Mission to Moldova (Chisinau, Beltsi and Tiraspol)
MAY 9: Meeting on the Evaluation of the 5% Initiative, Paris.
MAY 10: Meeting with WHO Europe Regional Director and HIV, TB and Hepatitis team, Copenhagen.
MAY 11: “TB and European Health Security: The critical role of TB R&D in the context of AMR”, Brussels.
MAY 14 – 16: International harm reduction conference, Montreal. SPEAKER
MAY 17 – 18: Aeras Board of Director, Washington DC.
MAY 21: “Antimicrobial resistance: Accessing new ways to tackle multi-drug resistant tuberculosis”, Global Health Centre at the Graduate Institute, Geneva. SPEAKER
MAY 22: 2nd Steering Committee meeting for the Moscow conference on Tuberculosis, Geneva.
MAY 22 – 26: World Health Assembly: bilateral meetings with the delegations of Tajikistan, Kyrgyzstan, Kazakhstan and Uzbekistan, Geneva.
MAY 30 – JUNE 1: Mission to Ukraine
JUNE 11 – 16: Mission to Uzbekistan
JUNE 19: Meeting on the Evaluation of the 5% Initiative, Paris. CHAIR
JUNE 22 – 23: Annual Advisory Board to the Public Health Program, Open Society Foundations, Budapest.
JUNE 26 – 28: Global Commission on Drug Policy Plenary meeting, Geneva.
JUNE 27 – 29: UNAIDS Programme Coordinating Board, Geneva.
JULY 12: Meeting on progress, challenges and opportunities to end AIDS by 2030 on the fifth anniversary of the Global Commission on HIV and the Law New York. SPEAKER
JULY 13: High Level Political Forum side event, New York. SPEAKER
JULY 23 – 26: AIDS Science conference, Paris. SPEAKER
JULY 27: IAS-Lancet Commission on the Future of the HIV Response and Global Health, Paris.
JULY 28 – 29: “Building Partnerships to Enhance Health and Criminal Justice Outcomes among pre incarcerated, incarcerated and soon to be released prisoners in Central Asia and Eastern Europe – A regional roundtable meeting of key stakeholders”, Kiev. SPEAKER
AUGUST 23 – 24: Aeras Board of Director, Washington DC.
SEPTEMBER 5 – 6: Global Drug Policy Program, Open Society Foundations, Advisory Board meeting, New York.
SEPTEMBER 11 – 13: WHO Euro Regional Committee, Budapest.
SEPTEMBER 14: 6th International City Health Conference, Basel. SPEAKER
OCTOBER 2: Side event at the Social Forum “Criminalization of drug users and how neglecting basic Human Rights to PWID fuels HIV transmission”, Geneva. SPEAKER
OCTOBER 3: Lancet-JHU Commission Drug Policy and Health event, Geneva. SPEAKER
OCTOBER 4: Launch of the French think tank “Solidarité et Santé”, Paris. SPEAKER
OCTOBER 6: Meeting on the Evaluation of the 5% Initiative, Paris. CHAIR
OCTOBER 11 – 13: The 48th Union World Conference on Lung Health, Guadalajara, Mexico. SPEAKER
OCTOBER 15 – 17: Meeting of the Coordination Conference Committee of the AIDS 2018, Amsterdam.
OCTOBER 18: TBVI Advisory Board, Amsterdam.
OCTOBER 24 – 26: Executive course “Drug Policy, Diplomacy and Global Public Health”, Geneva. CO-DIRECTOR
NOVEMBER 1 – 2: Aeras Board of Directors, Washington DC.
NOVEMBER 14: Global Health in Agenda 2030: Roundtable with DSG Amina Mohammed, Geneva. SPEAKER
NOVEMBER 16 – 17: Global Ministerial Conference on Ending TB in the Sustainable Development Era, Moscow.
NOVEMBER 21: “Lutte contre le sida, la tuberculose et le paludisme, fonds mondial et rôle de la France”, Friends of the Global Fund, Paris. SPEAKER
NOVEMBER 24: “A conversation on drug policy at the multilateral level”, Global Health Centre at the Graduate Institute, Geneva. MODERATOR
DECEMBER 1: “Are we on track to achieving epidemic control of HIV?”, Global Health Centre, Graduate Institute, Geneva. SPEAKER
DECEMBER 5: Seminar on new approaches to drug policy, Kiev. SPEAKER
DECEMBER 12: “The Lancet reviews on people who inject drugs and HIV: What do the new figures tell us and how should we respond”, Strategic advisory group to the UN on HIV and drug use, Geneva. SPEAKER
DECEMBER 12 – 14: UNAIDS Programme Coordinating Board, Geneva.
DECEMBER 21: Friends of the Global Fund Europe Board meeting, Brussels.
JANUARY 13-14: Accessibility Platform Meeting, Zurich. Moderator
JANUARY 18-19: Envoys Retreat, Geneva.
JANUARY 25-29: Mission to Donetsk and Luhansk.
FEBRUARY 3: TBVI Symposium “Tuberculosis vaccines and immunity”, Les Diablerets.
FEBRUARY 13-15: American Association for the Advancement of Science (AAAS) Annual Meeting, Washington DC. Speaker
FEBRUARY 22-24: Executive Course on Public Health and Drug Policy, Geneva. Course Director
MARCH 1-2: Mission to Kiev.
MARCH 3: Drug Policy Conference, Kiev. Speaker
MARCH 4-5: Mission to Donetsk.
MARCH 9-10: Hearing of the High Level Panel on Access to Medicines, London. Speaker
MARCH 14: Post-Croi 2016, Florence. Speaker
MARCH 15: Inaugural event of the Joep Lange Institute, Amsterdam.
MARCH 17: Briefing on HIV and TB with Permanent Representations to the EU, Brussels. Co-organizer
MARCH 23-25: Fifth International Eastern Europe and Central Asia AIDS Conference, Moscow. Speaker
APRIL 8: Meeting with WHO Europe Regional Director and HIV, TB and Hepatitis team, Copenhagen.
APRIL 18: Roundtable “Rethinking International Drug Policy: Adopting a Public Health Approach”, Centre for Strategic and International Studies (CSIS), Washington DC. Speaker
APRIL 19-21: UN General Assembly Special Session on Drugs, New York. Speaker
APRIL 21-23: Global Commission on Drug Policy Plenary Meeting, New York.
MAY 3-4: Meetings at UNDP, UNFPA and UN Women, Istanbul.
MAY 12-13: Third Regional Consultation on Harm Reduction in Eastern Europe and Central Asia, Odessa. Speaker
MAY 16-29: Mission to the Russian Federation.
MAY 30-31: International Conference “Actual Problems of HIV”, Saint Petersburg. Speaker
JUNE 6-7: Italian Conference on HIV/AIDS Research in 2016, Milan. Speaker
JUNE 8-10: UN High Level Meeting on HIV, New York. Speaker
JUNE 14: Friends of the Global Fund Conference, Paris. Speaker
JUNE 17: Side event “Addressing Migrants’ Access to Health, HIV and TB services in Eastern Europe and Central Asia” at the sidelines of the Human Rights Council, Geneva. Co-chair
JUNE 21: MILDECA Meeting, Paris. Speaker
JUNE 23: Panel “Multilateral Governance on Health”, Geneva Centre for Security Policy, Geneva. Speaker
JUNE 27: High Level event in the lead up to the Global Fund Replenishment, Rome. Speaker
JUNE 28-30: UNAIDS Programme Coordinating Board, Geneva.
JULY 6-8: Mission to Ukraine.
JULY 16-17: Tuberculosis Conference TB2016, Durban. Speaker
JULY 18-22: 21st International AIDS Conference, Durban. Speaker
JULY 24-26: EuroScience Open Forum (ESOF) 2016, Manchester. Speaker
SEPTEMBER 12-15: WHO Europe Regional Committee, Copenhagen.
SEPTEMBER 19: 5th City Health International Conference, London. Speaker
OCTOBER 10-14: Mission to Kazakhstan.
OCTOBER 12-13: National Conference on “HIV: yesterday, today and tomorrow”, Almaty. Speaker
NOVEMBER 2-3: Eastern Europe and Central Asia (EECA) Regional Consultation on Expanding Access to Affordable and Quality Assured Antiretroviral and Antituberculosis medicines, Minsk. Speaker
DECEMBER 5-9: Health and Diplomacy, Francophone course, Geneva. Course Director
DECEMBER 6-8: UNAIDS Programme Coordinating Board, Geneva.
JANUARY 7: Meeting with the High Commissioner on Human Rights, Geneva.
JANUARY 20: Crimea, Six months after discontinuation of OST, Geneva. Press briefing.
JANUARY 26-28: Meeting of the European Group of the Global Commission on Drug Policy, Brussels. Press briefing.
FEBRUARY 16: Audition of the Global Commission on Drug Policy by the UNGASS 2016 Board of the CND, Vienna. Speaker.
FEBRUARY 26: Santé et Droits Humains, Assemblée Nationale (Friends of the Global Fund), Paris. Speaker.
MARCH 4-6: Conference on Medical Use of Cannabis, Prague. Speaker.
MARCH 9-15: Commission on Narcotics and Drugs, Vienna.
MARCH 16: Access to Medicines for Hepatitis C, Médecins du Monde, Paris. Speaker.
MARCH 20: Visit to WHO Europe, Copenhagen.
MARCH 23-26: Visit to Armenia.
MARCH 30-31: European Ministerial Meeting on Tuberculosis, Riga. Speaker.
APRIL 20-24: International Forum on TB vaccines, Shangaï. Speaker.
MAY 4-6: 8th National Conference on Tuberculosis and Lung Diseases, Tashkent. Speaker.
MAY 18-22: World Health Assembly, Geneva.
MAY 19: Side event of the Global Commission on Drug Policy, World Health Assembly, Geneva.
MAY 26-28: Visit to Belarus.
JUNE 1-2: Séminaire Santé et Diplomatie, Global Health Program and ENA, Dakar. Speaker.
JUNE 17-18: High-Level Consultation ‘Addictions: Regulating Risk’, Brussels. Speaker.
JUNE 29-30: UNDP meeting on ‘Advancing the Recommendations of the Global Commission on HIV and the Law on HIV and people who use drugs’, New York. Speaker.
JULY 1-2: UNAIDS Programme Coordinating Board, Geneva. Statement.
JULY 8-9: Lancet Commission on Drugs, New York. Co-Chair.
JULY 19-22: IAS 2015, Vancouver. Plenary Speaker.
JULY 28-31: AIDS Impact 2015, Amsterdam. Speaker.
SEPTEMBER 1: Conference, Network of Biology Laboratories, Bern. Speaker.
SEPTEMBER 14-15: WHO European Regional Committee, Vilnius.
SEPTEMBER 15: Workshop at the Karolinska Institute, Stockholm. Speaker.
SEPTEMBER 25-28: UN General Assembly, New York.
OCTOBER 1-2: National Conference on Palliative Care, Kiev. Speaker.
OCTOBER 3-6: Plenary Session of the Global Commission on Drug Policy, Rabat.
OCTOBER 13: Symposium in Honor of Françoise Barré-Sinoussi, Paris. Speaker.
OCTOBER 14: Friends of the Global Fund, Paris.
OCTOBER 17-20: Harm Reduction Conference, Kuala Lumpur. Speaker.
OCTOBER 21-23: European AIDS Clinical Society Conference, Barcelona. Speaker.
OCTOBER 26-28: UNAIDS Programme Coordinating Board, Geneva.
NOVEMBER 4-7: World Science Forum, Budapest. Speaker.
NOVEMBER 6: Global Health Seminar, SciencesPo, Paris. Speaker. (TBC)
NOVEMBER 23-27: Health and Diplomacy, Francophone course, Dakar. Director.
NOVEMBER 30-2: Theravectys Side Meeting to the 46th Union World Conference on Lung Health, Cape Town.
DECEMBER 4-5: Champalimaud Foundation Conference, Lisbon. Speaker.
DECEMBER 7-8: International Steering Committee of the Robert Carr Fund, Amsterdam. Chair.
DECEMBER 9-11: Wilton Park Conference on AIDS in Europe. Speaker.